|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
47,410,000 |
Market
Cap: |
1.10(B) |
Last
Volume: |
380,567 |
Avg
Vol: |
363,246 |
52
Week Range: |
$22.61 - $57.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
13,116 |
13,116 |
27,398 |
35,584 |
Total Sell Value |
$468,797 |
$468,797 |
$1,165,795 |
$1,531,699 |
Total People Sold |
2 |
2 |
4 |
6 |
Total Sell Transactions |
4 |
4 |
9 |
11 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2024-04-01 |
4 |
AS |
$30.39 |
$45,585 |
D/D |
(1,500) |
72,784 |
|
-20% |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2024-03-18 |
4 |
AS |
$32.16 |
$60,622 |
D/D |
(1,885) |
50,954 |
|
-27% |
|
Carrel Michael H |
President, CEO, & Director |
|
2024-03-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
655,532 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2024-03-12 |
4 |
AS |
$36.72 |
$55,080 |
D/D |
(1,500) |
74,284 |
|
-34% |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2024-03-05 |
4 |
AS |
$37.36 |
$307,510 |
D/D |
(8,231) |
52,839 |
|
-39% |
|
Seith Douglas J |
Chief Operating Officer |
|
2024-03-01 |
4 |
D |
$36.28 |
$529,543 |
D/D |
(14,596) |
153,520 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
57,104 |
168,116 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2024-03-01 |
4 |
D |
$36.28 |
$321,296 |
D/D |
(8,856) |
75,784 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,622 |
84,640 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2024-03-01 |
4 |
OE |
$16.95 |
$84,750 |
D/D |
5,000 |
139,070 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
47,469 |
134,070 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2024-03-01 |
4 |
D |
$36.28 |
$321,259 |
D/D |
(8,855) |
59,077 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,622 |
67,932 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,281 |
61,070 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2024-03-01 |
4 |
D |
$36.28 |
$1,735,055 |
D/D |
(47,824) |
657,532 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
119,996 |
705,356 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2024-03-01 |
4 |
D |
$36.28 |
$266,803 |
D/D |
(7,354) |
98,290 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,427 |
105,644 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2024-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,056) |
47,219 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,294 |
49,275 |
|
- |
|
White Robert S. |
Director |
|
2024-02-23 |
4 |
OE |
$15.96 |
$159,600 |
D/D |
10,000 |
88,985 |
|
- |
|
Nachman Shlomo |
Director |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,322 |
5,322 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2023-12-29 |
4 |
A |
$30.34 |
$2,973 |
D/D |
98 |
29,981 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2023-11-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
585,360 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2023-08-06 |
4 |
D |
$57.23 |
$297,081 |
D/D |
(5,191) |
86,601 |
|
- |
|
958 Records found
|
|
Page 1 of 39 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|